This compound is a protected nucleoside derivative used as an intermediate in the synthesis of oligonucleotides. Its structure features a thymidine base with a benzamide modification and a dimethoxytrityl protecting group, which are typical for solid-phase DNA/RNA synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 104579-03-5
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-
nucleoside phosphoramidite building block intermediate
N4-Acetyl-2'-deoxycytidine
Nucleoside intermediate for oligonucleotide synthesis
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
Pharmaceutical intermediate for ambrisentan impurities
2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
Pharmaceutical intermediate for synthetic routes
N-(2-Amino-4,5,6,7-tetrahydro-6-benzothiazolyl)acetamide
Pharmaceutical intermediate for drug synthesis
2-(4-oxocyclohexyl)-2,3-dihydro-1H-isoindole-1,3-dione
Pharmaceutical intermediate synthesis
N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
nucleoside phosphoramidite building block intermediate
Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
DNA synthesis building block
N-[1-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxyoxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
YWHPQMVQHSPNRU-LBFZIJHGSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3C[C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O